Study guide

17.1 High-Alert Medications & Error-Prone Abbreviations

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

17.1 High-Alert Medications & Error-Prone Abbreviations

Key Takeaways Explain This Topic AI

High-alert medicines cause disproportionately severe harm when an error occurs — ISMP's list includes insulin, anticoagulants, opioids, concentrated electrolytes, weekly methotrexate, digoxin, neuromuscular blockers, and chemotherapy

Mitigation centres on independent double-checks, standardised concentrations, tall-man lettering, smart pumps with DERS, and segregation of concentrated electrolytes from floor stock

The abbreviation "U" for units has been misread as "0", causing 10-fold insulin overdoses; write "units" in full

Never use a trailing zero (1.0 mg) or omit a leading zero (.5 mg) — both produce 10-fold dosing errors

  • Weekly oral methotrexate must be labelled "WEEKLY"; daily dosing causes fatal pancytopenia and mucositis
  • Last updated: August 2026

High-Alert Medications

High-alert medications (also called high-risk medicines ) are drugs that carry a significantly elevated risk of causing serious patient harm when used in error. The Institute for Safe Medication Practices (ISMP) maintains the canonical list that the DHA blueprint draws from. A common exam trap is to assume "high-alert" means the drug is more error-prone — it does not. It means that when an error occurs, the consequences are more severe .

ISMP High-Alert Categories Every Pharmacist Must Know

  • Category Examples Typical Harm
  • Insulin (all formulations) Regular, glargine, U-100, U-500 Severe hypoglycaemia, brain damage, death
  • Anticoagulants Heparin (IV/SC), warfarin, apixaban, rivaroxaban, dabigatran, enoxaparin Major bleeding
  • Opioids Morphine, hydromorphone, fentanyl, methadone, oxycodone Respiratory depression, fatal overdose

Concentrated electrolytes Potassium chloride concentrate, hypertonic saline ≥3%, magnesium sulfate Cardiac arrest, hyperkalaemia

  • Methotrexate (oral, weekly) Rheumatoid arthritis / psoriasis doses Pancytopenia if given daily
  • Digoxin Tablets, elixir Arrhythmia, toxicity
  • Neuromuscular blockers Rocuronium, suxamethonium, vecuronium Respiratory paralysis if not ventilated
  • Chemotherapy Vincristine, IV methotrexate, doxorubicin Cytotoxic catastrophe
  • Oral hypoglycaemics Sulfonylureas (glibenclamide, glimepiride) Severe, prolonged hypoglycaemia
  • Risk-Reduction Strategies

The pharmacist's role is to engineer safety into the system so that a single human slip does not reach the patient:

Independent double-check : two qualified clinicians separately verify drug, dose, route, rate, and patient identity before administering high-alert IV medicines. The check is independent — neither clinician tells the other what they expect to see.

Standardised concentrations : heparin 25,000 units/250 mL, morphine 1 mg/mL, insulin infusion 1 unit/mL. Standardisation removes calculation steps.

Tall-man lettering : capitalise distinctive parts of look-alike names — predniSONE vs prednisoLONE , DOBUTamine vs DOPamine , hyDROmorphone vs morphine , NIFEdipine vs niCARdipine .

Smart pumps with dose error-reduction software (DERS) : hard upper limits on opioid, heparin, and insulin infusion rates; the pump refuses to deliver above the soft or hard cap.

Segregation and limited access : concentrated potassium chloride and hypertonic saline ≥3% must be stored outside patient-care areas, never as floor stock; heparin flushes separated from heparin infusions.

Exam Trap — Methotrexate Weekly, Not Daily

A classic DHA-style stem exploits the weekly oral methotrexate regimen used for rheumatoid arthritis and psoriasis. Prescribing or dispensing it as "daily" causes fatal pancytopenia, mucositis, and sepsis. Always verify the frequency is once weekly (sometimes split into three divided doses 12 hours apart on the same day of the week) and label the box "WEEKLY" with a prominent warning. Oncology methotrexate, by contrast, may be high-dose IV on a multi-day cycle — the route and indication change the risk profile.

Error-Prone Abbreviations (ISMP Do-Not-Use List)

The ISMP List of Error-Prone Abbreviations, Symbols, and Dose Designations catalogues notations linked to harmful medication errors. The DHA exam tests the most dangerous entries.

  • Prohibited Why It's Dangerous Write Instead
  • U or u (for units) Misread as "0" — insulin 10U read as 100 units, 10-fold overdose units
  • IU (international unit) Misread as "IV" (intravenous) or "1" international unit
  • QD , Q.D. , q.d. Mistaken for QID (four times daily) daily
  • QOD , q.o.d. Mistaken for QD or QID every other day
  • Trailing zero (1.0 mg) Decimal missed — given as 10 mg 1 mg
  • Missing leading zero (.5 mg) Decimal missed — given as 5 mg 0.5 mg
  • MS , MSO4 , MgSO4 Confusion between morphine sulfate and magnesium sulfate morphine , magnesium sulfate
  • cc (cubic centimetre) Misread as "U" (units) mL
  • μg (microgram) Misread as mg — 1000-fold overdose mcg or microgram
  • @ , & , > , < Ambiguous in handwriting "at", "and", "greater than", "less than"
  • AS , AD , AU (ear) Confused with OS/OD (eye) — wrong site "left ear", "right ear", "both ears"
  • The 10-Fold Error Pattern

Almost every exam question on this topic tests the 10-fold dosing error . Three mechanisms produce it:

"U" → "0" : 6U regular insulin read as 60 units .

Missing leading zero : .5 mg digoxin read as 5 mg (10× the dose).

Trailing zero : 1.0 mg warfarin read as 10 mg .

These are sentinel events. The corrective rule is always the same: write the unit word in full, never append a trailing zero, and never omit a leading zero.

  • Tall-Man Lettering Pairs to Memorise
  • DOBUTamine vs DOPamine — very different haemodynamic profiles
  • hyDROmorphone vs morphine — hydromorphone is roughly 5–7× more potent
  • predniSONE vs prednisoLONE — different potencies and indications
  • cycloSERINE vs cycloSPORINE — anti-tubercular vs immunosuppressant
  • chlorPROmazine vs chloramphenicol — antipsychotic vs antibiotic
  • NIFEdipine vs niCARdipine — different onset and clinical use

When a question shows a handwritten or transcribed order with any of the abbreviations above, the safest pharmacist action is almost always to contact the prescriber to clarify — never guess, never "interpret" a prohibited abbreviation.